Interventions for maintenance of surgically induced remission in Crohn’s disease: a systematic review and network meta-analysis
Morris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran · 2025
Read Interventions for maintenance of surgically induced remission in Crohn’s disease: a systematic review and network meta-analysis by Morris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12718597.txt.
Description
Morris Gordon and four colleagues compare drugs for holding Crohn's disease quiet after surgery, in a twenty twenty-five review. About half of Crohn's patients need surgery, and many relapse after it. The team pooled thirty-four trials with 3,197 patients in a network analysis. Outcomes were symptom relapse, scope-seen relapse, and quitting from side effects.
One biologic drug, adalimumab, clearly cut symptom relapse against placebo, with fair-grade proof. Two older drug families may cut relapse slightly, on weaker proof. Another biologic probably cut scope-seen relapse. Most other options rested on very weak proof. The authors grade each claim so doctors can weigh certainty, not just effect size.
Catalog record
| CREATOR | Morris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |